Iterum Therapeutics (ITRM) Stock Price
Iterum Therapeutics Price
Revenue at Iterum Therapeutics has contracted by 73.0% per year over the past 2 years to 37,000.00 USD. Iterum Therapeutics's net margin stands at -278,729.7%, down from -5,788.6% several years earlier.
Iterum Therapeutics stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Iterum Therapeutics business model & stock analysis
Frequently asked questions about Iterum Therapeutics
8 analysts currently rate the Iterum Therapeutics stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Iterum Therapeutics to generate revenue of 10.00 M USD and earnings per share of -0.65 USD.
Converted at the current exchange rate, the Iterum Therapeutics share trades at 0.00 EUR (0.00 USD).
The Iterum Therapeutics share (ITRM) is listed on 1 stock exchanges, including: NASDAQ (ITRM).
The expected revenue of Iterum Therapeutics is 10.00 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Iterum Therapeutics is -12.79 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Iterum Therapeutics is currently -0.00. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Iterum Therapeutics stock.
The price-to-sales ratio (P/S) of Iterum Therapeutics is currently 0.00. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Iterum Therapeutics stock.
The Eulerpool Quality Score for Iterum Therapeutics is 3/10.
The ISIN of Iterum Therapeutics is IE000TTOOBX0. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Iterum Therapeutics is A2JMZP. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Iterum Therapeutics is ITRM. The ticker symbol is used to trade Iterum Therapeutics shares on the stock exchange.
Iterum Therapeutics stock
Iterum Therapeutics Peer Group
Iterum Therapeutics Ticker
All fundamentals and in-depth analysis of Iterum Therapeutics
Our stock analysis for Iterum Therapeutics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Iterum Therapeutics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.